Study of Postprandial Incretin Response in Women With Gestational Diabetes
Reduced Postprandial GLP-1 Response in Gestational Diabetes Mellitus: a Fully Reversible Phenomenon
1 other identifier
observational
19
1 country
1
Brief Summary
The researchers investigated nineteen pregnant women in third trimester and again postpartum. At the experimental days we performed a mealtest and drew blood for analyses of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), insulin, C-peptide and glucagon. The researchers aimed to investigate whether women with gestational diabetes mellitus exhibit decreased postprandial GLP-1 responses, and if so, whether this deficiency ceases following delivery when normal glucose tolerance is reestablished.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 10, 2011
CompletedFirst Posted
Study publicly available on registry
January 11, 2011
CompletedJanuary 11, 2011
January 1, 2011
1.3 years
January 10, 2011
January 10, 2011
Conditions
Keywords
Study Arms (2)
Gestational Diabetes Mellitus
Women with Gestational Diabetes Mellitus
Normal Glucose Tolerance
Women with Normal Glucose Tolerance
Interventions
Eligibility Criteria
Healthy pregnant woman were examined with a 75 g oral glucose tolerance test. Subjects with plasma glucose (PG) values at 120 min \>9.0 mmol/l were diagnosed with gestational diabetes and subjects with PG \<9.0 mmol/l were enrolled as healthy controls.
You may qualify if:
- Normal haemoblobin
- Willingness to participate
You may not qualify if:
- First degree relative with diabetes
- Diabetes before pregnancy
- Positive islet cell- and GAD-65 autoantibodies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Gentofte, Copenhagenlead
- The Danish Diabetes Associationcollaborator
- Aase and Ejnar Danielsens Foundationcollaborator
- The Novo Nordic Foundationcollaborator
Study Sites (1)
Department of Internal Medicine, Glostrup Hospital
Glostrup Municipality, 2600, Denmark
Related Publications (1)
Hare KJ, Bonde L, Svare JA, Randeva HS, Asmar M, Larsen S, Vilsboll T, Knop FK. Decreased plasma chemerin levels in women with gestational diabetes mellitus. Diabet Med. 2014 Aug;31(8):936-40. doi: 10.1111/dme.12436. Epub 2014 Apr 1.
PMID: 24628007DERIVED
Biospecimen
Blood Plasma
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Filip K Knop, MD PhD
Diabetes Research Division, Gentofte Hopsital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 10, 2011
First Posted
January 11, 2011
Study Start
March 1, 2007
Primary Completion
July 1, 2008
Study Completion
July 1, 2008
Last Updated
January 11, 2011
Record last verified: 2011-01